Novel PD-1 blockade bioassay to assess therapeutic antibodies in PD-1 and PD-L1 immunotherapy programs

被引：9
|
作者：
Cheng, Zhi-Jie Jey [1 ]
Karassina, Natasha [1 ]
Grailer, Jamison [1 ]
Hartnett, Jim [1 ]
Fan, Frank [1 ]
Cong, Mei [1 ]
机构：
[1] Promega Corp, Madison, WI USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5440
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1
    Jiang, Mengzhen
    Liu, Man
    Liu, Guodi
    Ma, Jiawen
    Zhang, Lixin
    Wang, Shenlin
    MABS, 2023, 15 (01)
  • [32] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [33] Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway
    Barclay, Jonathan
    Creswell, Joanne
    Leon, Juan
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (04): : 393 - 399
  • [34] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [35] Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
    Escors, David
    Bocanegra, Ana
    Chocarro, Luisa
    Blanco, Ester
    Pineiro-Hermida, Sergio
    Garnica, Maider
    Fernandez-Rubio, Leticia
    Vera, Ruth
    Arasanz, Hugo
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [36] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] Targeting PD-1/PD-L1 interactions for cancer immunotherapy
    Zitvogel, Laurence
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2012, 1 (08): : 1223 - 1225
  • [38] Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
    Yuan, Yu
    Adam, Abdalla
    Zhao, Chen
    Chen, Honglei
    CANCERS, 2021, 13 (04) : 1 - 18
  • [39] A novel combinatorial cancer immunotherapy poly-IC and blockade of the PD-1/PD-L1 pathway
    Nagato, Toshihiro
    Celis, Esteban
    ONCOIMMUNOLOGY, 2014, 3 (05)
  • [40] A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
    Girault, Isabelle
    Adam, Julien
    Shen, Shensi
    Roy, Severine
    Brard, Caroline
    Faouzi, Sara
    Routier, Emilie
    Lupu, Jeremy
    Warren, Sarah
    Sorg, Kristina
    Ong, SuFey
    Morel, Pascale
    Scoazec, Jean-Yves
    Vagner, Stephan
    Robert, Caroline
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 518 - 525
12345